BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33879657)

  • 1. The clinical prognostic value of lncRNA LINC00675 in cancer patients: A meta-analysis.
    Hua H; Wang J; Zhong P; Mou T; Liu P; Xie F
    Medicine (Baltimore); 2021 Apr; 100(16):e25244. PubMed ID: 33879657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinicopathological significance of long non-coding RNA UCA1 in colorectal cancer: Results from a meta-analysis.
    Liu X; Liu X; Qiao T; Chen W
    Medicine (Baltimore); 2019 Nov; 98(48):e18031. PubMed ID: 31770217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of long non-coding RNA plasmacytoma variant translocation1 in human solid tumors: A meta-analysis.
    Zou B; Wang D; Xu K; Liu JL; Yuan DY; Meng Z; Zhang B
    Medicine (Baltimore); 2019 Jul; 98(27):e16087. PubMed ID: 31277104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
    Tian S; Liu J; Kong S; Peng L
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Non-Coding RNA TUG1 as a Potential Novel Biomarker for Predicting the Clinical Outcome of Cancer Patients: a Meta-Analysis.
    Li B; Shen S; Zhang W; Qi T; Hu Q; Cheng Y
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549987
    [No Abstract]   [Full Text] [Related]  

  • 7. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
    Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
    Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.
    Liu FT; Pan H; Xia GF; Qiu C; Zhu ZM
    Oncotarget; 2016 Dec; 7(50):83177-83186. PubMed ID: 27825121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PCAT-1 in gastrointestinal cancers: A meta-analysis.
    Liu W; Xu J
    Medicine (Baltimore); 2018 Nov; 97(48):e13429. PubMed ID: 30508953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA X-inactive specific transcript as a prognostic factor in cancer patients: A meta-analysis based on retrospective studies.
    Chen J; Yang X; Gong D; Cui Y; Hu J; Li H; Liu P; Li C; Cheng X; Liu L; Chen H; Zu X
    Medicine (Baltimore); 2019 Jan; 98(3):e14095. PubMed ID: 30653128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
    Zhang G; Cai J
    J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
    Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
    Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA GAS5 can predict metastasis and poor prognosis: a meta-analysis.
    Song W; Wang K; Zhang RJ; Dai QX; Zou SB
    Minerva Med; 2016 Feb; 107(1):70-6. PubMed ID: 26763654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA PVT1 in cancer: A review and meta-analysis.
    Lu D; Luo P; Wang Q; Ye Y; Wang B
    Clin Chim Acta; 2017 Nov; 474():1-7. PubMed ID: 28866116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis.
    Shi D; Wu F; Gao F; Qing X; Shao Z
    PLoS One; 2017; 12(6):e0179346. PubMed ID: 28594897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA XIST predicts worse prognosis in digestive system tumors: a systemic review and meta-analysis.
    Liu X; Ming X; Jing W; Luo P; Li N; Zhu M; Yu M; Liang C; Tu J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.